Structures by: Rao K. S.
Total: 20
C8H14N4OS
C8H14N4OS
CrystEngComm (2005) 7, 62 374
a=6.450(2)Å b=9.401(4)Å c=9.965(4)Å
α=76.674(5)° β=76.909(5)° γ=70.190(5)°
C8H14N4OS
C8H14N4OS
CrystEngComm (2005) 7, 62 374
a=14.182(9)Å b=9.295(6)Å c=8.723(5)Å
α=90° β=104.309(10)° γ=90°
Atovaquone
C22H19ClO3
CrystEngComm (2013) 15, 24 4871
a=5.9369(7)Å b=18.358(2)Å c=16.6699(18)Å
α=90° β=97.334(2)° γ=90°
Cis-Atovaquone
C22H19ClO3
CrystEngComm (2013) 15, 24 4871
a=13.2516(10)Å b=10.9285(9)Å c=12.6302(10)Å
α=90° β=95.450(1)° γ=90°
2-cyclohexyl-3-hydroxynaphthalene-1,4-dione
C16H16O3
CrystEngComm (2013) 15, 24 4871
a=14.401(3)Å b=5.3279(9)Å c=17.393(3)Å
α=90° β=98.926(3)° γ=90°
Trans- 2-(4-tert-butylcyclohexyl)-3-hydroxynaphthalene-1,4-dione
C20H15O3
CrystEngComm (2013) 15, 24 4871
a=5.9504(7)Å b=12.4798(15)Å c=12.9769(16)Å
α=107.582(2)° β=100.950(2)° γ=103.635(2)°
Cis-2-(4-(4-chlorophenyl) cyclohexyl) -3-chloronaphthalene-1,4-dione
C22H18Cl2O2
CrystEngComm (2013) 15, 24 4871
a=5.9770(18)Å b=12.226(4)Å c=13.103(4)Å
α=103.814(5)° β=90.038(4)° γ=95.271(6)°
Trans -2-(4-(4-chlorophenyl)cyclohexyl)-3-chloronaphthalene-1,4-dione
C22H18Cl2O2
CrystEngComm (2013) 15, 24 4871
a=10.3671(11)Å b=7.0515(7)Å c=25.102(2)Å
α=90° β=99.777(2)° γ=90°
Cis-2-(4-(4-chlorophenyl)cyclohexyl)-3-nitronaphthalene-1,4-dione
C22H18ClNO4
CrystEngComm (2013) 15, 24 4871
a=11.7512(16)Å b=12.7998(18)Å c=13.985(2)Å
α=75.766(3)° β=67.022(2)° γ=83.020(3)°
Captafol
C10H9Cl4NO2S
Acta Crystallographica Section E (2004) 60, 12 o2406-o2407
a=10.567(8)Å b=6.674(5)Å c=19.427(15)Å
α=90° β=91.715(12)° γ=90°
Acetamiprid
C10H11ClN4
Acta Crystallographica Section E (2004) 60, 12 o2374-o2375
a=8.776(3)Å b=11.780(5)Å c=10.645(4)Å
α=90° β=90° γ=90°
2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol
C14H17Cl2N3O
Acta Crystallographica Section E (2004) 60, 12 o2410-o2412
a=10.895(6)Å b=11.006(6)Å c=13.595(8)Å
α=90° β=106.526(9)° γ=90°
Imidachloprid
C9H10ClN5O2
Acta Crystallographica Section E (2004) 60, 12 o2415-o2417
a=19.290(8)Å b=4.839(2)Å c=11.784(5)Å
α=90° β=99.220(6)° γ=90°
Thiamethaxam
C8H10ClN5O3S
Acta Crystallographica Section E (2004) 60, 12 o2413-o2414
a=6.493(5)Å b=28.74(2)Å c=6.812(5)Å
α=90° β=105.486(12)° γ=90°
Pyrazosulfuron-ethyl
C14H18N6O7S
Acta Crystallographica Section E (2004) 60, 12 o2418-o2420
a=9.263(3)Å b=14.038(4)Å c=15.137(5)Å
α=90° β=105.294(5)° γ=90°
Kresoxim methyl
C18H19NO4
Acta Crystallographica Section E (2004) 60, 12 o2421-o2423
a=16.843(16)Å b=15.480(14)Å c=13.728(13)Å
α=90° β=114.337(14)° γ=90°
Isoprothiolane
C12H18O4S2
Acta Crystallographica Section E (2005) 61, 1 o3-o5
a=10.400(7)Å b=9.117(6)Å c=32.09(2)Å
α=90° β=90° γ=90°
6-tert-Butyl-4-isopropylideneamino-3-methylsulfanyl-1,2,4-triazin-5(4H)-one
C11H18N4OS
Acta Crystallographica Section E (2005) 61, 4 o1112-o1114
a=9.797(2)Å b=10.290(3)Å c=13.856(3)Å
α=90° β=90° γ=90°
Azoxystrobin
C22H16N3O5
Acta Crystallographica Section E (2007) 63, 11 o4493-o4493
a=28.946(6)Å b=10.803(2)Å c=13.302(3)Å
α=90° β=94.61(3)° γ=90°
Atovaquone
C22H19ClO3
CrystEngComm (2013) 15, 24 4871
a=12.548(2)Å b=5.2674(9)Å c=27.842(5)Å
α=90° β=92.573(3)° γ=90°